Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
Newletter
Events

Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
Newletter
Events

Category: Uncategorized

Dominating the Chronic Care Matrix: Analyzing Viatris’ 5-Year Journey and Strategic Originator Localization in Vietnam

30/06/2026 Published by Pharma Biz

Key Development Global healthcare aggregator Viatris (Nasdaq: VTRS) has successfully concluded a high-profile national scientific symposium series titled "Non-Communicable Diseases... Read more

Tags: #Vietnam

Late-Stage Asset Crystallization: Analyzing Ipsen’s $1.7 Billion Strategic Acquisition of Kartos Therapeutics

29/06/2026 Published by Pharma Biz

Key Development Global biopharmaceutical leader Ipsen (Euronext: IPN; ADR: IPSEY) has formally entered into a definitive merger agreement to acquire... Read more

Category: Uncategorized

Tags: #M&A

Chemistry, Manufacturing, and Controls Bottlenecks: Analyzing the FDA’s Complete Response Letter for Sobi’s Gout Biologic

29/06/2026 Published by Pharma Biz

Key Development Global specialized biopharmaceutical leader Swedish Orphan Biovitrum AB (Sobi) has officially announced the receipt of a Complete Response... Read more

Category: Uncategorized

Tags: #Global Trends

Reversing Corporate Criminal Exposure: US DOJ Closes Criminal Investigation into Abbott Over Baby Formula Plant Missteps

29/06/2026 Published by Pharma Biz

Key Development The U.S. Department of Justice (DOJ) has officially closed its multi-year criminal investigation into healthcare giant Abbott Laboratories... Read more

Category: Uncategorized

Tags: #Global Trends

Clinical Data Integrity Collapses: Analyzing EMA’s Recommendation to Revoke Amgen’s Orphan Drug Authorization for Tavneos

29/06/2026 Published by Pharma Biz

Key Development The European Medicines Agency (EMA) has formally issued a negative regulatory recommendation, calling for the revocation of the... Read more

Category: Uncategorized

Tags: #Global Trends

The GLP-1 Warfare in China: Pfizer and Innovent Clear Preliminary National Insurance Hurdles for a Billion-Citizen Market

29/06/2026 Published by Pharma Biz

Key Development China's National Healthcare Security Administration (NHSA) has officially released its updated regulatory ledger showing that next-generation GLP-1 receptor... Read more

Category: Uncategorized

Tags: #Global Trends

The Illiquidity Premium Valuation: Analyzing Tam Duc Heart Hospital’s Post-Bonus Share Surge

29/06/2026 Published by Pharma Biz

Key Development According to official regulatory disclosures submitted to the State Securities Commission of Vietnam, Tam Duc Heart Hospital Joint... Read more

Category: Uncategorized

Tags: #Vietnam

The 4-6 Golden Minutes That Decide Survival

27/06/2026 Published by Pharma Biz

The first few minutes can make the difference between life, death, and lasting disability. Every day, emergencies such as sudden... Read more

Category: Uncategorized

Tags: #Corporate Wellness

Beyond the spreadsheet: Four systemic failures in corporate decision rights

27/06/2026 Published by Pharma Biz

To streamline cross-functional collaboration, accelerate execution velocity, and mitigate internal friction within complex frameworks, enterprises frequently turn to decision-rights toolkits... Read more

Category: Uncategorized

Tags: #Human Resources

Posts pagination

Previous page Page 1 … Page 67 Page 68 Page 69 … Page 227 Next page

Facebook

Map

Workday: Monday to Friday
Working hours: 8am to 5pm
Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

Please enable JavaScript in your browser to complete this form.

Email

Email *

Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates

Category: Uncategorized

Facebook

Map

Online Members